Literature DB >> 3620320

An overview of published results from randomized studies of nitrosoureas in primary high grade malignant glioma.

S P Stenning, L S Freedman, N M Bleehen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3620320      PMCID： PMC2001669          DOI： 10.1038/bjc.1987.161

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


× No keyword cloud information.
  5 in total

1.  A comparison of radiotherapy alone with radiotherapy and CCNU in cerebral glioma.

Authors:  M J Garrett; H J Hughes; L S Freedman
Journal:  Clin Oncol       Date:  1978-03

2.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.

Authors:  M D Walker; E Alexander; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; H A Norrell; G Owens; J Ransohoff; C B Wilson; E A Gehan; T A Strike
Journal:  J Neurosurg       Date:  1978-09       Impact factor: 5.115

3.  Adjuvant nitrosourea therapy for glioblastoma.

Authors:  R Brisman; E M Housepian; C Chang; P Duffy; E Balis
Journal:  Arch Neurol       Date:  1976-11

4.  Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Authors:  M D Walker; S B Green; D P Byar; E Alexander; U Batzdorf; W H Brooks; W E Hunt; C S MacCarty; M S Mahaley; J Mealey; G Owens; J Ransohoff; J T Robertson; W R Shapiro; K R Smith; C B Wilson; T A Strike
Journal:  N Engl J Med       Date:  1980-12-04       Impact factor: 91.245

5.  Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.

Authors:  C H Chang; J Horton; D Schoenfeld; O Salazer; R Perez-Tamayo; S Kramer; A Weinstein; J S Nelson; Y Tsukada
Journal:  Cancer       Date:  1983-09-15       Impact factor: 6.860
  5 in total
  20 in total

1.  Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.

Authors:  L Chauveinc; M T Sola-Martinez; M Martin-Duverneuil; J J Mazeron; T Faillot; P Cornu; L Capelle; J Y Delattre; M Poisson; F Baillet; J Chiras
Journal:  J Neurooncol       Date:  1996-02       Impact factor: 4.130

Review 2.  The treatment of primary malignant brain tumours.

Authors:  I R Whittle; A Gregor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-02       Impact factor: 10.154

3.  Retrospective study of carmustine or lomustine with bevacizumab in recurrent glioblastoma patients who have failed prior bevacizumab.

Authors:  Rifaquat Rahman; Kelly Hempfling; Andrew D Norden; David A Reardon; Lakshmi Nayak; Mikael L Rinne; Rameen Beroukhim; Lisa Doherty; Sandra Ruland; Arun Rai; Jennifer Rifenburg; Debra LaFrankie; Brian M Alexander; Raymond Y Huang; Patrick Y Wen; Eudocia Q Lee
Journal:  Neuro Oncol       Date:  2014-06-23       Impact factor: 12.300

Review 4.  Management of primary malignant brain tumours.

Authors:  I R Whittle
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-01       Impact factor: 10.154

5.  Activity and toxicity of carboplatin and iproplatin in relapsed high-grade glioma.

Authors:  C J Twelves; C M Ash; D W Miles; D G Thomas; R L Souhami
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

6.  The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group.

Authors:  R Sposto; I J Ertel; R D Jenkin; C P Boesel; J L Venes; J A Ortega; A E Evans; W Wara; D Hammond
Journal:  J Neurooncol       Date:  1989-07       Impact factor: 4.130

7.  Radiation therapy combined with radiosensitizing agents for cerebral glioblastoma in adults.

Authors:  M Matsutani; O Nakamura; M Nakamura; T Nagashima; A Asai; T Fujimaki; H Tanaka; K Ueki; Y Tanaka
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  Comparative analysis of temozolomide (TMZ) versus 1,3-bis (2-chloroethyl)-1 nitrosourea (BCNU) in newly diagnosed glioblastoma multiforme (GBM) patients.

Authors:  Mridula Vinjamuri; Rakesh R Adumala; Ramin Altaha; Gerald R Hobbs; Edward B Crowell
Journal:  J Neurooncol       Date:  2008-09-24       Impact factor: 4.130

9.  Phase 2 trial of BCNU plus irinotecan in adults with malignant glioma.

Authors:  David A Reardon; Jennifer A Quinn; Jeremy N Rich; Sridharan Gururangan; James Vredenburgh; John H Sampson; James M Provenzale; Amy Walker; Michael Badruddoja; Sandra Tourt-Uhlig; James E Herndon; Jeannette M Dowell; Mary Lou Affronti; Susanne Jackson; Deborah Allen; Karen Ziegler; Steven Silverman; Cindy Bohlin; Allan H Friedman; Darell D Bigner; Henry S Friedman
Journal:  Neuro Oncol       Date:  2004-04       Impact factor: 12.300

10.  A phase II clinical trial of poly-ICLC with radiation for adult patients with newly diagnosed supratentorial glioblastoma: a North American Brain Tumor Consortium (NABTC01-05).

Authors:  Nicholas Butowski; Susan M Chang; Larry Junck; Lisa M DeAngelis; Lauren Abrey; Karen Fink; Tim Cloughesy; Kathleen R Lamborn; Andres M Salazar; Michael D Prados
Journal:  J Neurooncol       Date:  2008-09-17       Impact factor: 4.130
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.